![Vivek Subbiah: Cancer remains the second leading cause of death after heart disease in the US, 2019-2023](https://oncodaily.com/pub/uploads/2024/08/1674666840345-e1725177869793.png)
Vivek Subbiah: Cancer remains the second leading cause of death after heart disease in the US, 2019-2023
Vivek Subbiah shared a post on LinkedIn:
“Leading Causes of Death in the US, 2019-2023.
Interesting how the healthcare landscape has changed in 4 yrs.
Cancer remains the 2nd leading cause of death after heart disease – JAMA Oncology
All the more reason for all of us to work harder, smarter & faster in Cancer Research & Clinical Trials.”
Authors: Farida B. Ahmad, Jodi A. Cisewski, Robert N. Anderson.
Source: Vivek Subbiah/LinkedIn
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023